Muhlenkamp & Co’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-700
| Closed | -$13K | – | 58 |
|
|
2017
Q4 | $13K | Hold |
700
| – | – | ﹤0.01% | 51 |
|
|
2017
Q3 | $12K | Sell |
700
-105,805
| -99% | -$1.81M | ﹤0.01% | 50 |
|
|
2017
Q2 | $3.54M | Sell |
106,505
-140
| -0.1% | -$4.65K | 1.11% | 29 |
|
|
2017
Q1 | $3.42M | Sell |
106,645
-133,244
| -56% | -$4.28M | 1.05% | 30 |
|
|
2016
Q4 | $8.7M | Buy |
239,889
+64,119
| +36% | +$2.32M | 2.75% | 16 |
|
|
2016
Q3 | $8.09M | Sell |
175,770
-885
| -0.5% | -$40.7K | 3.05% | 14 |
|
|
2016
Q2 | $8.87M | Sell |
176,655
-505
| -0.3% | -$25.4K | 3.47% | 10 |
|
|
2016
Q1 | $9.48M | Buy |
177,160
+205
| +0.1% | +$11K | 3.87% | 8 |
|
|
2015
Q4 | $11.6M | Hold |
176,955
| – | – | 3.49% | 12 |
|
|
2015
Q3 | $9.99M | Buy |
176,955
+40
| +0% | +$2.26K | 2.93% | 15 |
|
|
2015
Q2 | $10.5M | Buy |
176,915
+205
| +0.1% | +$12.1K | 2.26% | 21 |
|
|
2015
Q1 | $11M | Buy |
176,710
+325
| +0.2% | +$20.2K | 2.32% | 22 |
|
|
2014
Q4 | $10.1M | Sell |
176,385
-470
| -0.3% | -$27K | 2.03% | 23 |
|
|
2014
Q3 | $9.51M | Hold |
176,855
| – | – | 1.72% | 27 |
|
|
2014
Q2 | $9.27M | Buy |
176,855
+1,415
| +0.8% | +$74.2K | 1.64% | 29 |
|
|
2014
Q1 | $9.27M | Sell |
175,440
-900
| -0.5% | -$47.6K | 1.63% | 27 |
|
|
2013
Q4 | $7.07M | Buy |
176,340
+6,355
| +4% | +$255K | 1.23% | 29 |
|
|
2013
Q3 | $6.42M | Buy |
169,985
+325
| +0.2% | +$12.3K | 1.28% | 29 |
|
|
2013
Q2 | $6.65M | Buy |
+169,660
| New | +$6.65M | 1.39% | 28 |
|